Visual masking in schizophrenia: overview and theoretical implications

Schizophr Bull. 2011 Jul;37(4):700-8. doi: 10.1093/schbul/sbr051. Epub 2011 May 23.

Abstract

Visual masking provides several key advantages for exploring the earliest stages of visual processing in schizophrenia: it allows for control over timing at the millisecond level, there are several well-supported theories of the underlying neurobiology of visual masking, and it is amenable to examination by electroencephalogram (EEG) and functional magnetic resonance imaging (fMRI). In this paper, we provide an overview of the visual masking impairment schizophrenia, including the relevant theoretical mechanisms for masking impairment. We will discuss its relationship to clinical symptoms, antipsychotic medications, diagnostic specificity, and presence in at-risk populations. As part of this overview, we will cover the neural correlates of visual masking based on recent findings from EEG and fMRI. Finally, we will suggest a possible mechanism that could explain the patterns of masking findings and other visual processing findings in schizophrenia.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use
  • Brain / drug effects
  • Brain / physiopathology*
  • Electroencephalography / drug effects
  • Humans
  • Interneurons / drug effects
  • Interneurons / physiology
  • Magnetic Resonance Imaging
  • Neural Inhibition / physiology
  • Neurons / drug effects
  • Neurons / physiology
  • Neurotransmitter Agents / metabolism
  • Pattern Recognition, Visual / drug effects
  • Pattern Recognition, Visual / physiology
  • Perceptual Disorders / diagnosis
  • Perceptual Disorders / physiopathology*
  • Perceptual Disorders / psychology
  • Risk Factors
  • Schizophrenia / diagnosis
  • Schizophrenia / drug therapy
  • Schizophrenia / physiopathology*
  • Schizophrenic Psychology*
  • Schizotypal Personality Disorder / diagnosis
  • Schizotypal Personality Disorder / drug therapy
  • Schizotypal Personality Disorder / physiopathology
  • Schizotypal Personality Disorder / psychology
  • Social Adjustment
  • Visual Pathways / drug effects
  • Visual Pathways / physiopathology
  • Visual Perception / drug effects
  • Visual Perception / physiology*
  • gamma-Aminobutyric Acid / metabolism

Substances

  • Antipsychotic Agents
  • Neurotransmitter Agents
  • gamma-Aminobutyric Acid